Literature DB >> 12844484

Mitochondrial complex I is deficient in renal oncocytomas.

Helene Simonnet1, Jocelyne Demont, Kathy Pfeiffer, Leila Guenaneche, Raymonde Bouvier, Ulrich Brandt, Hermann Schagger, Catherine Godinot.   

Abstract

Renal oncocytomas are benign tumors characterized by dense accumulation of mitochondria the cause of which remains unknown so far. Consistently, mitochondrial DNA content and the amounts and catalytic activities of several oxidative phosphorylation (OXPHOS) complexes were known to be increased in these tumors, but it was not ascertained that the OXPHOS system was functional. Here we investigated mitochondrial complex I and found that its NADH dehydrogenase activity and protein content were specifically decreased in oncocytomas, in stark contrast with the parallel decrease of all respiratory chain complexes in other, malignant, renal tumors. We conclude that deficiency of complex I in oncocytomas might be the early event causing the increased mitochondrial biogenesis, attempting to compensate for the loss of OXPHOS function. Since other tumors were found to be linked to mitochondrial deficiencies like genetic alterations of fumarate hydratase or succinate dehydrogenase, oncocytoma could be the third type of benign tumor associated with impairment of mitochondrial ATP production in an oxidative, quiescent tissue. Besides, complex I enzyme activity was moderately decreased in the vicinity of oncocytomas, when compared with normal tissue adjacent to other renal tumors. This suggested that oncocytomas are the result of at least two serial modifications altering the mitochondrial respiratory chain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12844484     DOI: 10.1093/carcin/bgg109

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

2.  Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review.

Authors:  Jabi Shriki; Venkatesh Murthy; Jeffrey Brown
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 3.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

4.  Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells.

Authors:  Aleksandr Klepinin; Vladimir Chekulayev; Natalja Timohhina; Igor Shevchuk; Kersti Tepp; Andrus Kaldma; Andre Koit; Valdur Saks; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2013-09-27       Impact factor: 2.945

5.  Deficiency of the complex I of the mitochondrial respiratory chain but improved adenylate control over succinate-dependent respiration are human gastric cancer-specific phenomena.

Authors:  Marju Puurand; Nadežda Peet; Andres Piirsoo; Margot Peetsalu; Jaan Soplepmann; Meeli Sirotkina; Ants Peetsalu; Akseli Hemminki; Enn Seppet
Journal:  Mol Cell Biochem       Date:  2012-07-21       Impact factor: 3.396

Review 6.  Mitochondrial metabolism inhibitors for cancer therapy.

Authors:  Emma E Ramsay; Philip J Hogg; Pierre J Dilda
Journal:  Pharm Res       Date:  2011-09-15       Impact factor: 4.200

7.  Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia.

Authors:  Katarína Smolková; Nadège Bellance; Francesca Scandurra; Elisabeth Génot; Erich Gnaiger; Lydie Plecitá-Hlavatá; Petr Jezek; Rodrigue Rossignol
Journal:  J Bioenerg Biomembr       Date:  2010-01-19       Impact factor: 2.945

8.  Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis.

Authors:  Maria V Yusenko; Thomas Ruppert; Gyula Kovacs
Journal:  Int J Biol Sci       Date:  2010-04-23       Impact factor: 6.580

Review 9.  Relevance of mitochondrial genetics and metabolism in cancer development.

Authors:  Giuseppe Gasparre; Anna Maria Porcelli; Giorgio Lenaz; Giovanni Romeo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 10.  Actuality of Warburg's views in our understanding of renal cancer metabolism.

Authors:  Catherine Godinot; Elodie de Laplanche; Eric Hervouet; Hélène Simonnet
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.